CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 272 filers reported holding CUBIST PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $4,378,000 | -68.9% | 43,503 | -79.5% | 0.00% | -71.4% |
| Q3 2014 | $14,084,000 | -1.2% | 212,303 | +4.0% | 0.01% | 0.0% |
| Q2 2014 | $14,250,000 | -9.8% | 204,103 | -5.5% | 0.01% | -17.6% |
| Q1 2014 | $15,800,000 | +38.6% | 215,995 | +30.5% | 0.02% | +30.8% |
| Q4 2013 | $11,399,000 | -4.1% | 165,509 | -11.5% | 0.01% | -13.3% |
| Q3 2013 | $11,890,000 | -49.5% | 187,096 | -61.6% | 0.02% | -50.0% |
| Q2 2013 | $23,536,000 | – | 487,278 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Quinn Opportunity Partners LLC | 328,000 | $33,013,000 | 15.74% |
| Cheyne Capital Management (UK) LLP | 373,372 | $37,593,000 | 9.88% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 897,136 | $90,296,000 | 9.71% |
| Andromeda Capital LLC | 76,760 | $7,726,000 | 9.71% |
| Palo Alto Investors LP | 1,303,668 | $131,214,000 | 7.70% |
| Andromeda Capital LLC | 50,000 | $5,033,000 | 6.32% |
| QVT Financial LP | 1,200,000 | $120,780,000 | 6.04% |
| HARVEST MANAGEMENT LLC | 42,500 | $4,278,000 | 6.03% |
| Sandell Investment Services LLC | 58,525 | $5,891,000 | 5.62% |
| Kellner Capital, LLC | 70,200 | $7,066,000 | 4.83% |